FDA Approves 'Biosimilar' Drug Ogivri for Breast, Stomach Cancers

Title: FDA Approves 'Biosimilar' Drug Ogivri for Breast, Stomach CancersCategory: Health NewsCreated: 12/1/2017 12:00:00 AMLast Editorial Review: 12/4/2017 12:00:00 AM

http://www.medicinenet.com/script/main/art.asp?articlekey=208662

Source: MedicineNet Cancer General - December 4, 2017 Category: Cancer & Oncology Source Type: news

More News: Cancer | Cancer & Oncology | Gastric (Stomach) Cancer